U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750678) titled 'Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy' on Aug. 02.
Brief Summary: The goal of this clinical trial is to evaluate the safety and efficacy of GEB-101 injection in subjects with TGFBI-related Corneal Dystrophy
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Hereditary Corneal Dystrophy
Corneal Abnormality
Corneal Dystrophies
Corneal Dystrophies, Hereditary
Intervention:
GENETIC: GEB-101 Injection
Single intrastromal injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: GenEditBio Limited
Published by HT Digital Content Services with permission fro...